Welcome to LookChem.com Sign In|Join Free

CAS

  • or

54-95-5

Post Buying Request

54-95-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

54-95-5 Usage

Description

Pentylenetetrazole (PTZ) is a central nervous system modulator that is used to experimentally induce seizures in animals. Subcutaneous PTZ has been used extensively to screen for compounds that block the production of nonconvulsive (absence or myoclonic) seizures. PTZ has diverse, site-specific effects in the brain. However, it is an antagonist of GABAA receptors and some drugs that block PTZ-induced seizures, including benzodiazepines, act at the GABAA receptor.

Chemical Properties

white crystalline powder

Originator

Pentylenetetrazole,Spectrum Chemicals and

Uses

Different sources of media describe the Uses of 54-95-5 differently. You can refer to the following data:
1. Pentylenetetrazole has been used to induce seizures in zebra fish larvae, mice, and male wistar rats.
2. Non-specific CNS stimulant; convulsant; narcotic antagonist.
3. analeptic, circulation stimulant

Definition

ChEBI: An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other espiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.

Manufacturing Process

A solution of 9.8 g cyclohexanone and 8.6 g HNO3 in about 250 ml benzene were slowly added dropwise to 20 ml concentrate sulfuric acid in 100 ml benzene by ice cooling and stirring. After ending of a generation of N2 (0.1 moles) to a corresponding quantity of cyclohexane (0.1 moles). Acid layer was diluted with ice, and made neutral with strong alkaline to give a reaction product as oil. Then it was exrtacted with chloroform, all solvents were distilled and the residue was diluted with water. The desired 6,7,8,9tetrahydro-5H-tetrazoloazepine dropped. Yield was 7.5 g after recrystallization from ester or distillation. M.P: 65°C.

Brand name

Cardiazol (Knoll).

Therapeutic Function

Analeptic, Central stimulant

General Description

White crystalline powder or granular solid with a slightly pungent odor. Bitter taste. Aqueous solutions neutral to litmus.

Air & Water Reactions

Dust can be explosive when suspended in air at specific concentrations. Water soluble.

Reactivity Profile

Pentetrazol is incompatible with oxidizing agents. . Azo, diazo, azido compounds can detonate. This applies in particular to organic azides that have been sensitized by the addition of metal salts or strong acids. Toxic gases are formed by mixing materials of this class with acids, aldehydes, amides, carbamates, cyanides, inorganic fluorides, halogenated organics, isocyanates, ketones, metals, nitrides, peroxides, phenols, epoxides, acyl halides, and strong oxidizing or reducing agents. Flammable gases are formed by mixing materials in this group with alkali metals. Explosive combination can occur with strong oxidizing agents, metal salts, peroxides, and sulfides. Azo dyes can be explosive when suspended in air at specific concentrations.

Fire Hazard

Flash point data for Pentetrazol are not available. Pentetrazol is probably combustible.

Biological Activity

CNS stimulant that induces kindling in vivo . Causes alterations in excitatory and inhibitory neurotransmitter systems.

Biochem/physiol Actions

Pentylenetetrazole is a non-specific central nervous system (CNS) stimulant and convulsant. PTZ induces oxidative stress and increases cortical malondialdehyde content and affects hippocampus, resulting in seizures.

Safety Profile

A human poison by ingestion and intravenous routes. Poison experimentally by ingestion, intravenous, intraperitoneal, subcutaneous, rectal, and parenteral routes. When heated to decomposition it emits toxic fumes of NOx.

Purification Methods

pKEst Crystallise metrazol from diethyl ether and dry it under vacuum over P2O5, or distil it. [Schmidt Chem Ber 57 704 1924, Beilstein 26 II 213.]

Check Digit Verification of cas no

The CAS Registry Mumber 54-95-5 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 5 and 4 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 54-95:
(4*5)+(3*4)+(2*9)+(1*5)=55
55 % 10 = 5
So 54-95-5 is a valid CAS Registry Number.
InChI:InChI=1/C6H10N4/c1-2-4-6-7-8-9-10(6)5-3-1/h1-5H2

54-95-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L16185)  1,5-Pentamethylene-1H-tetrazole, 98%   

  • 54-95-5

  • 5g

  • 195.0CNY

  • Detail
  • Alfa Aesar

  • (L16185)  1,5-Pentamethylene-1H-tetrazole, 98%   

  • 54-95-5

  • 25g

  • 560.0CNY

  • Detail
  • Sigma

  • (P6500)  Pentylenetetrazole  

  • 54-95-5

  • P6500-25G

  • 819.00CNY

  • Detail

54-95-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name pentetrazol

1.2 Other means of identification

Product number -
Other names 6,7,8,9-tetrahydro-5H-tetrazolo[1,5-a]azepine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:54-95-5 SDS

54-95-5Synthetic route

cyclohexanone
108-94-1

cyclohexanone

pentetrazole
54-95-5

pentetrazole

Conditions
ConditionsYield
With sodium azide; tetrachlorosilane In acetonitrile for 20h; Ambient temperature;95%
With aluminium trichloride; sodium azide at 50℃; for 0.2h;95%
With tin(II) chloride dihdyrate; trimethylsilylazide In neat (no solvent) at 55℃; for 16h; Schmidt Reaction; Inert atmosphere; Sealed tube;87%
cyclohexanone oxime methanesulfonate
80053-69-6

cyclohexanone oxime methanesulfonate

pentetrazole
54-95-5

pentetrazole

Conditions
ConditionsYield
With trimethylsilyl trifluoromethanesulfonate In acetonitrile for 24h; Heating;94%
cyclohexanone
108-94-1

cyclohexanone

A

pentetrazole
54-95-5

pentetrazole

B

4,5,6,7,8,9-hexahydrotetrazolo[1,5-a][1,3]diazocine

4,5,6,7,8,9-hexahydrotetrazolo[1,5-a][1,3]diazocine

Conditions
ConditionsYield
With trifluorormethanesulfonic acid; trimethylsilylazide at 20℃; for 2h; Schmidt Reaction; Inert atmosphere; Sealed tube;A 91%
B 4%
1-azacycloheptane-2-thione
7203-96-5

1-azacycloheptane-2-thione

pentetrazole
54-95-5

pentetrazole

Conditions
ConditionsYield
With sodium azide; tetrachlorosilane In acetonitrile at 20 - 82℃; for 8h;88%
With trimethylsilylazide; tin(IV) chloride In dichloromethane for 22h; Ambient temperature;72%
With tetrahydrofuran; aluminium trichloride; sodium azide
cyclohexanone oxime benzoyl ester
29456-22-2

cyclohexanone oxime benzoyl ester

pentetrazole
54-95-5

pentetrazole

Conditions
ConditionsYield
With trimethylsilyl trifluoromethanesulfonate In acetonitrile for 24h; Heating;84%
Cyclohexanone oxime
100-64-1

Cyclohexanone oxime

pentetrazole
54-95-5

pentetrazole

Conditions
ConditionsYield
With diphenyl phosphoryl azide; 1,8-diazabicyclo[5.4.0]undec-7-ene In toluene for 16h; Solvent; Beckmann Rearrangement; Reflux; stereospecific reaction;81%
With chlorosulfonic acid; sodium azide
With sodium azide; trichlorophosphate
6-aminohexanoic acid
60-32-2

6-aminohexanoic acid

pentetrazole
54-95-5

pentetrazole

Conditions
ConditionsYield
With trimethylsilylazide; trichlorophosphate In acetonitrile at 180℃; for 0.133333h; Microwave irradiation;76%
1,2,3-trimethoxybenzene
621-23-8

1,2,3-trimethoxybenzene

cycloheptanone
502-42-1

cycloheptanone

A

pentetrazole
54-95-5

pentetrazole

B

(E)-8-(2,4,6-trimethoxyphenyl)-2,3,4,5,6,7-hexahydroazocinium bromide

(E)-8-(2,4,6-trimethoxyphenyl)-2,3,4,5,6,7-hexahydroazocinium bromide

Conditions
ConditionsYield
With aluminum tri-bromide; trimethylsilylazide at 35℃; for 21h; Temperature; Schmidt Reaction; Inert atmosphere;A 18%
B 66%
trimethylsilylazide
4648-54-8

trimethylsilylazide

cyclohexanone
108-94-1

cyclohexanone

A

pentetrazole
54-95-5

pentetrazole

B

1-azido-1-(trimethylsiloxy)cyclohexane
69664-68-2

1-azido-1-(trimethylsiloxy)cyclohexane

Conditions
ConditionsYield
With tin(ll) chloride 1.) 0 deg C 2.) rt., 20 h;A 2%
B 61%
caprolactam
105-60-2

caprolactam

pentetrazole
54-95-5

pentetrazole

Conditions
ConditionsYield
With chlorosulfonic acid; tris-(2-chloro-ethyl)-amine
With sodium azide; trichlorophosphate
O-methylcaprolactim
2525-16-8

O-methylcaprolactim

pentetrazole
54-95-5

pentetrazole

Conditions
ConditionsYield
With tris-(2-chloro-ethyl)-amine
Multi-step reaction with 2 steps
1: chloroform
2: water; acetic acid; NaNO2
View Scheme
7-ethylsulfanyl-3,4,5,6-tetrahydro-2H-azepine
85028-07-5

7-ethylsulfanyl-3,4,5,6-tetrahydro-2H-azepine

pentetrazole
54-95-5

pentetrazole

Conditions
ConditionsYield
With tris-(2-chloro-ethyl)-amine
hexahydro-azepin-2-one-hydrazone
31030-25-8

hexahydro-azepin-2-one-hydrazone

pentetrazole
54-95-5

pentetrazole

Conditions
ConditionsYield
With water; acetic acid; sodium nitrite
7-ethoxy-3,4,5,6-tetrahydro-2H-azepine
13414-33-0

7-ethoxy-3,4,5,6-tetrahydro-2H-azepine

pentetrazole
54-95-5

pentetrazole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrazine hydrate
2: water; acetic acid; NaNO2
View Scheme
5-(5-bromo-pentyl)-1H-tetrazole

5-(5-bromo-pentyl)-1H-tetrazole

pentetrazole
54-95-5

pentetrazole

Conditions
ConditionsYield
With phenol In N,N-dimethyl-formamide
perchloric acid
7601-90-3

perchloric acid

pentetrazole
54-95-5

pentetrazole

1-ferrocenylmethanol
1273-86-5

1-ferrocenylmethanol

3(4)-(ferrocenylmethylene)-1,5-pentamethylenetetrazolium perchlorate

3(4)-(ferrocenylmethylene)-1,5-pentamethylenetetrazolium perchlorate

Conditions
ConditionsYield
In dichloromethane; water aq. HClO4 was added to mixt. of corazol and Fe-complex in CH2Cl2, 12 min, Et2O was added; filtered, washed with ether, dried; elem. anal.;100%
pentetrazole
54-95-5

pentetrazole

1-ferrocenylmethanol
1273-86-5

1-ferrocenylmethanol

antimony(III) chloride
10025-91-9

antimony(III) chloride

3(4)-(ferrocenylmethylene)-1,5-pentamethylenetetrazolium trichlorohydroxystibate

3(4)-(ferrocenylmethylene)-1,5-pentamethylenetetrazolium trichlorohydroxystibate

Conditions
ConditionsYield
In dichloromethane SbCl3 was added to mixt. of corazol and Fe-complex in CH2Cl2, stirred for 25 min, treated with Et2O, left to stand for 10 d at 4-5°C; filtered, washed with Et2O, dried at room temp.; elem. anal.;100%
tetrafluoroboric acid

tetrafluoroboric acid

pentetrazole
54-95-5

pentetrazole

1-ferrocenylmethanol
1273-86-5

1-ferrocenylmethanol

3(4)-(ferrocenylmethylene)-1,5-pentamethylenetetrazolium tetrafluoroborate

3(4)-(ferrocenylmethylene)-1,5-pentamethylenetetrazolium tetrafluoroborate

Conditions
ConditionsYield
In dichloromethane; water aq. HBF4 was added to mixt. of corazol and Fe-complex in CH2Cl2, 15 min,Et2O was added; filtered, washed with ether, dried; elem. anal.;99%
pentetrazole
54-95-5

pentetrazole

nickel(II) perchlorate hexahydrate

nickel(II) perchlorate hexahydrate

Ni(2+)*6C6H10N4*2ClO4(1-)={Ni(C6H10N4)6}(ClO4)2

Ni(2+)*6C6H10N4*2ClO4(1-)={Ni(C6H10N4)6}(ClO4)2

Conditions
ConditionsYield
In further solvent(s) stirring 0.01 mol Ni(ClO4)2*6H2O in 2.2-dimethoxy-propane for 5-10 min, addn. of small excess of C6H10N4 (0.08 mol);; pptn., washing with cooled ether (several times), drying at ambient temp.;;95%
potassium tetrachloroplatinate(II)
10025-99-7

potassium tetrachloroplatinate(II)

pentetrazole
54-95-5

pentetrazole

cis-Pt(pentamethylenetetrazole)2I2
76625-16-6

cis-Pt(pentamethylenetetrazole)2I2

Conditions
ConditionsYield
With KI In water addn. of excess KI to Pt-complex, then addn. of 2 equiv. ligand (pptn.); filtration, washing (H2O), drying (60°C, vac., over P2O5); elem.anal.;95%
pentetrazole
54-95-5

pentetrazole

potassium tetrachloropalladate(II)
10025-98-6

potassium tetrachloropalladate(II)

cis-Pd(pentamethylenetetrazole)2I2
76625-14-4

cis-Pd(pentamethylenetetrazole)2I2

Conditions
ConditionsYield
With KI In water addn. of excess KI to Pd-complex, then addn. of 2 equiv. ligand (pptn.); filtration, washing (H2O), drying (60°C, vac., over P2O5); elem.anal.;95%
pentetrazole
54-95-5

pentetrazole

1,5-pentamethylenetetrazole-3-oxide
1221230-55-2

1,5-pentamethylenetetrazole-3-oxide

Conditions
ConditionsYield
With acetonitrile complex of hypofluorous acid In dichloromethane at 0℃;95%
tetrafluoroboric acid

tetrafluoroboric acid

pentetrazole
54-95-5

pentetrazole

1-ferrocenylethanol
1277-49-2

1-ferrocenylethanol

C5H5FeC5H4CHCH3N4C(CH2)5(1+)*BF4(1-)=C5H5FeC5H4CHCH3N4C(CH2)5BF4

C5H5FeC5H4CHCH3N4C(CH2)5(1+)*BF4(1-)=C5H5FeC5H4CHCH3N4C(CH2)5BF4

Conditions
ConditionsYield
In dichloromethane; water aq. HBF4 was added to mixt. of corazol and Fe-complex in CH2Cl2, 15 min,Et2O was added; filtered, washed with ether, dried; elem. anal.;94%
perchloric acid
7601-90-3

perchloric acid

pentetrazole
54-95-5

pentetrazole

1-ferrocenylethanol
1277-49-2

1-ferrocenylethanol

C5H5FeC5H4CHCH3N4C(CH2)5(1+)*ClO4(1-)=C5H5FeC5H4CHCH3N4C(CH2)5ClO4

C5H5FeC5H4CHCH3N4C(CH2)5(1+)*ClO4(1-)=C5H5FeC5H4CHCH3N4C(CH2)5ClO4

Conditions
ConditionsYield
In dichloromethane; water aq. HClO4 was added to mixt. of corazol and Fe-complex in CH2Cl2, 15 min, Et2O was added; filtered, washed with ether, dried; elem. anal.;92%
pentetrazole
54-95-5

pentetrazole

nickel(II) perchlorate

nickel(II) perchlorate

Ni(2+)*6C6H10N4*2ClO4(1-)={Ni(C6H10N4)6}(ClO4)2

Ni(2+)*6C6H10N4*2ClO4(1-)={Ni(C6H10N4)6}(ClO4)2

Conditions
ConditionsYield
In water addn. of 20-fold excess of C6H10N4 to aq. soln. of Ni(ClO4)2, storing for 5-10 d;; crystn.;91%
pentetrazole
54-95-5

pentetrazole

(C5(CH3)5)2SmI(OC4H8)

(C5(CH3)5)2SmI(OC4H8)

(C5(CH3)5)2SmI(C6H10N4)

(C5(CH3)5)2SmI(C6H10N4)

Conditions
ConditionsYield
In toluene N2;; crystn. at -34°C within several h, recrystn., elem. anal.;;90%
potassium tetrachloroplatinate(II)
10025-99-7

potassium tetrachloroplatinate(II)

pentetrazole
54-95-5

pentetrazole

cis-Pt(pentamethylenetetrazole)2Cl2
76847-85-3

cis-Pt(pentamethylenetetrazole)2Cl2

Conditions
ConditionsYield
In water addn. of 2 equiv. ligand to Pt-complex, stirring (room temp., pptn.); filtration, washing (H2O), drying (60°C, vac., over P2O5); elem.anal.;90%
potassium tetrachloroplatinate(II)
10025-99-7

potassium tetrachloroplatinate(II)

pentetrazole
54-95-5

pentetrazole

cis-Pt(pentamethylenetetrazole)2Br2
76625-15-5

cis-Pt(pentamethylenetetrazole)2Br2

Conditions
ConditionsYield
With KBr In water addn. of excess KBr to Pt-complex, then addn. of 2 equiv. ligand (pptn.); filtration, washing (H2O), drying (60°C, vac., over P2O5); elem.anal.;90%
pentetrazole
54-95-5

pentetrazole

potassium tetrachloropalladate(II)
10025-98-6

potassium tetrachloropalladate(II)

cis-Pd(pentamethylenetetrazole)2Br2
76625-13-3

cis-Pd(pentamethylenetetrazole)2Br2

Conditions
ConditionsYield
In water addn. of 2 equiv. ligand to Pd-complex, stirring (room temp., pptn.); filtration, washing (H2O), drying (60°C, vac., over P2O5); elem.anal.;90%
With KBr In water addn. of excess KBr to Pd-complex, then addn. of 2 equiv. ligand (pptn.); filtration, washing (H2O), drying (60°C, vac., over P2O5); elem.anal.;90%
pentetrazole
54-95-5

pentetrazole

potassium tetrachloropalladate(II)
10025-98-6

potassium tetrachloropalladate(II)

cis-Pd(pentamethylenetetrazole)2Cl2
76625-12-2

cis-Pd(pentamethylenetetrazole)2Cl2

Conditions
ConditionsYield
In water addn. of 2 equiv. ligand to Pd-complex, stirring (room temp., pptn.); filtration, washing (H2O), drying (60°C, vac., over P2O5); elem.anal.;90%
pentetrazole
54-95-5

pentetrazole

benzaldehyde
100-52-7

benzaldehyde

acetyl chloride
75-36-5

acetyl chloride

phenyl(6,7,8,9-tetrahydro-5H-tetrazolo[1,5-a]azepin-9-yl)methyl acetate
926290-85-9

phenyl(6,7,8,9-tetrahydro-5H-tetrazolo[1,5-a]azepin-9-yl)methyl acetate

Conditions
ConditionsYield
Stage #1: pentetrazole With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.5h;
Stage #2: benzaldehyde In tetrahydrofuran; hexane at -78℃; for 0.333333h;
Stage #3: acetyl chloride In tetrahydrofuran; hexane at -78 - 20℃;
81%
pentetrazole
54-95-5

pentetrazole

copper(II) perchlorate hexahydrate

copper(II) perchlorate hexahydrate

tetrakis(1,5-pentamethylenetetrazol)copper(II) perchlorate

tetrakis(1,5-pentamethylenetetrazol)copper(II) perchlorate

Conditions
ConditionsYield
In isopropyl alcohol tetrazole deriv. added to soln. of copper perchlorate in isopropanol under stirring; mixt. heated at 60°C for 1 h; cooling at 17°C; small amt. of ethyl acetate added; ppt. filteredoff, washed with ethyl acetate and recrystd. from isopropanol; elem. an al.;80%
In water tetrazole deriv. added to aq. soln. of copper perchlorate under stirring; mixt. heated at 60°C for 2 h; cooling at 17°C; ppt. filtered off, washed with ethyl acetate andrecrystd. from isopropanol; elem. anal.;60%
tetrafluoroboric acid

tetrafluoroboric acid

pentetrazole
54-95-5

pentetrazole

vinyl ferrocene
1271-51-8

vinyl ferrocene

C5H5FeC5H4CHCHCH2N4C(CH2)5(1+)*BF4(1-)=C5H5FeC5H4CHCHCH2N4C(CH2)5BF4

C5H5FeC5H4CHCHCH2N4C(CH2)5(1+)*BF4(1-)=C5H5FeC5H4CHCHCH2N4C(CH2)5BF4

Conditions
ConditionsYield
In dichloromethane; water aq. HBF4 was added to mixt. of corazol and Fe-complex in CH2Cl2, 40 min,Et2O was added; filtered, washed with ether, dried; elem. anal.;63%
tetrafluoroboric acid

tetrafluoroboric acid

pentetrazole
54-95-5

pentetrazole

1-ferrocenylphenylmethanol

1-ferrocenylphenylmethanol

C5H5FeC5H4CHC6H5N4C(CH2)5(1+)*BF4(1-)=C5H5FeC5H4CHC6H5N4C(CH2)5BF4

C5H5FeC5H4CHC6H5N4C(CH2)5(1+)*BF4(1-)=C5H5FeC5H4CHC6H5N4C(CH2)5BF4

Conditions
ConditionsYield
In dichloromethane; water aq. HBF4 was added to mixt. of corazol and Fe-complex in CH2Cl2, 30 min,Et2O was added; filtered, washed with ether, dried; elem. anal.;62%
pentetrazole
54-95-5

pentetrazole

copper(II) perchlorate

copper(II) perchlorate

copper(II) perchlorate bis(1,5-pentamethylentetrazole)

copper(II) perchlorate bis(1,5-pentamethylentetrazole)

Conditions
ConditionsYield
In water at 20 - 60℃;60%
pentetrazole
54-95-5

pentetrazole

cobalt(III) diaquatetrammine perchlorate

cobalt(III) diaquatetrammine perchlorate

A

tetraammine-bis(cyclopentamethylenetetrazole)cobalt(III) perchlorate

tetraammine-bis(cyclopentamethylenetetrazole)cobalt(III) perchlorate

B

tetraammine(aqua)(cyclopentamethylenetetrazole)cobalt(III) perchlorate

tetraammine(aqua)(cyclopentamethylenetetrazole)cobalt(III) perchlorate

Conditions
ConditionsYield
In hydrogenchloride complex Co(NH3)4(H2O)2(ClO4)3 reacted with cyclopentamethylenetetrazole in aq. soln. of HCl for 3 h at 100°C; complex (Co(NH3)4(C6H10N4))(ClO4)3 isolated; mother liquor concd.; ppt. formed upon cooling filtered off; elem. anal.;A 59%
B 38%

54-95-5Relevant articles and documents

Preparation of 1,5-fused tetrazoles under solvent-free conditions

Eshghi, Hossein,Hassankhani, Asadollah

, p. 1115 - 1120 (2005)

A facile and efficient procedure is developed for a one-pot synthesis of fused 1,5-disubstituted tetrazoles from cyclic ketones and sodium azide in the presence of aluminum chloride in solvent-free media. Advantages of this method are chemoselectivity, with high yields in a simple operation, and short reaction time under solvent-free conditions. Copyright Taylor & Francis, Inc.

An Interrupted Schmidt Reaction: C-C Bond Formation Arising from Nitrilium Ion Capture

Charaschanya, Manwika,Li, Kelin,Motiwala, Hashim F.,Aubé, Jeffrey

supporting information, p. 6354 - 6358 (2018/10/15)

The rerouting of the nitrilium ion formed in the Schmidt reaction of ketones and TMSN3 to encompass C-C bond formation with an electron-rich aromatic group is reported. Thus, when the reaction is carried out in HFIP using AlCl3 or Al

Convergent Three-Component Tetrazole Synthesis

Chandgude, Ajay L.,D?mling, Alexander

, p. 2383 - 2387 (2016/06/01)

A microwave-accelerated, simple, and efficient method for the construction of the 1,5-tetrazole scaffold was developed. It comprises a multicomponent reaction of an amine, a carboxylic acid derivative, and an azide source. On the basis of the availability of the archetypical starting materials, this method provided very versatile synthetic access to 1,5-disubstituted tetrazoles. The usefulness of this method was demonstrated in the synthesis of biologically important fused tetrazole scaffolds and the marketed drug cilostazol.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 54-95-5